Will GHRP-2 affect testosterone or my HPG axis?

GHRP-2's effect on the HPG axis depends on its primary mechanism. Direct HPG-axis engagement is not the principal mechanism, but indirect effects via inflammation, metabolic status, or hepatic SHBG may produce hormone shifts that warrant baseline and follow-up labs. The standard male monitoring panel applies.

Should I cycle GHRP-2?

Standard cycle for GHRP-2 is 8–12 weeks of 2-3x daily subq 100-300 mcg dosing via subq, followed by a 4 week complete off-period. The off-period is calibrated to GHRP-2's ~15-60 min half-life and to typical receptor downregulation timelines. Continuous indefinite dosing does not show additional clinical benefit in the published literature and increases cumulative downregulation risk.

How should GHRP-2 be stored and reconstituted?

Lyophilised GHRP-2 stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

How does GHRP-2's half-life affect dosing?

GHRP-2 has a plasma half-life of ~15-60 min, which is short enough to require multiple daily doses to maintain therapeutic exposure. The receptor occupancy curve under 2-3x daily subq dosing at 100-300 mcg per dose explains the typical onset timeline for male hormonal and performance endpoints.

What should I look for in GHRP-2 sourcing and quality?

Acceptable GHRP-2 certificates of analysis specify: lot-specific (not template) issuance, HPLC purity ≥98%, mass spec confirmation matching 817 Da, endotoxin testing for injectable routes, and third-party accredited laboratory issuance. Template COAs, missing endotoxin data, or vendor-internal labs are red flags. Pharmaceutical-grade compounded material is the lowest-risk supply path where accessible.

Home/ Compounds/ GHRP-2

GHRP-2

Men's Health

Male-physiology practitioners evaluate GHRP-2 against the HPG axis, androgenic markers, and downstream effects on body composition, libido, and recovery. Selective ghrelin/GHSR receptor agonist on pituitary somatotrophs Stimulates a pulsatile GH release. Mildly raises ACTH/cortisol and prolactin compared to ipamorelin.. For men running GHRP-2 alongside TRT, post-cycle restarts, or fertility-aware protocols, baseline labs (total/free testosterone, LH, FSH, estradiol, prolactin, SHBG) and a 6-8 week follow-up panel are the standard monitoring framework at the 100-300 mcg 2-3x daily subq dose.

Male Physiology Applications

HPG Axis SupportHair LossMuscle MassStrength & PowerRecovery

Key Takeaways

Male-physiology lens: GHRP-2 is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations.
Mechanism: Selective ghrelin/GHSR receptor agonist on pituitary somatotrophs.
Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel.
Male dose: 100-300 mcg 2-3x daily subq via subq; cycle 8-12 weeks.
Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.

Male Physiology Mechanism

Selective ghrelin/GHSR receptor agonist on pituitary somatotrophs. Stimulates a pulsatile GH release. Mildly raises ACTH/cortisol and prolactin compared to ipamorelin. For men, the downstream consequences of this mechanism are evaluated against four operational domains: HPG-axis interaction, recovery and body composition, sexual function and prostate, and integration with concurrent TRT or HCG protocols. GHRP-2's relationship to each is examined below.

Compatibility with TRT and post-cycle protocols

For men currently on TRT or planning a post-cycle restart, GHRP-2 is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.

Sexual function and prostate considerations

Where GHRP-2 alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.

Male body composition and performance response

Male users typically respond to GHRP-2 on the recovery, lean-mass, or visceral-fat dimension depending on the compound's primary pharmacology. Selective ghrelin/GHSR receptor agonist on pituitary somatotrophs. Stimulates a pulsatile GH release. Mildly raises ACTH/cortisol and prolactin compared to ipamorelin. For men whose body composition goals are driven by training, the dose-timing relative to workouts and sleep is often the critical lever rather than the absolute dose itself.

Male Physiology Applications

Muscle Mass

Where male users target muscle mass, GHRP-2 is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Cardiovascular Health (Male)

Cardiovascular Health (Male) in men responds to GHRP-2 with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.

HPG Axis Support

For hpg axis support in male users, GHRP-2 is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.

Body Composition (Male)

Where male users target body composition (male), GHRP-2 is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	100-300 mcg	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	60-300 mcg	4–6 weeks initial cycle
Men's Health focus	SubQ	100-300 mcg	2-3x daily SubQ
Maintenance phase	SubQ	70-300 mcg	Ongoing with periodic pauses

Dose timing for GHRP-2 is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

GHRP-2 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.

GHRP-2 + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with GHRP-2's mechanism in male physiology protocols.
GHRP-2 + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with GHRP-2's mechanism in male physiology protocols.
GHRP-2 + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with GHRP-2's mechanism in male physiology protocols.
GHRP-2 + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with GHRP-2's mechanism in male physiology protocols.

Safety & Regulatory Status

WADA: Banned (S2) FDA: Approved in Japan for GH stimulation testing only

More prolactin/cortisol effect than ipamorelin. Pair with GHRH for synergy.

Lens-specific safety considerations for male physiology use of GHRP-2: More prolactin/cortisol effect than ipamorelin. Pair with GHRH for synergy. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

GHRP-2 mechanism of GH secretion

PMID 12679487

Supporting

Pralmorelin / GHRP-2 clinical use

PMID 10221681

GHRP-2 vs Related Peptides

Compound	Profile	Onset	Best For
GHRP-2	Growth hormone releasing peptide	~15-60 min	Men's Health
Kisspeptin	Hypothalamic upstream regulator of GnRH	~28 min IV	The upstream master regulator of GnRH neurons — driving the entire HPG axis from above
Gonadorelin (GnRH)	Hypothalamic decapeptide	~2-4 min	The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy
PT-141	Melanocortin receptor agonist	~2-3 hr	An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women

Frequently Asked Questions

Will GHRP-2 affect fertility or sperm quality?

Sperm parameters reflect a 70–90 day spermatogenic cycle, so any meaningful effect on sperm count and motility requires at least one full cycle to manifest. GHRP-2's direct effect on spermatogenesis varies by mechanism. Men actively pursuing fertility should baseline semen analysis before and after cycles to track.

What blood work should I run on this protocol?

Standard male protocol baseline: total and free testosterone, LH, FSH, estradiol (sensitive), prolactin, SHBG, fasting glucose, HbA1c, hsCRP, lipid panel, CBC, CMP. Follow-up at week 6–8 with the same panel. Add IGF-1 for any GH-axis compound. Add PSA for men over 40.

Best time of day to dose for male users?

The pragmatic schedule is morning fasted for compounds engaging the GH axis (preserving the natural overnight pulse), evening for compounds supporting sleep, and PRN for compounds with acute effects (PT-141, etc.). The schedule should fit the user's daily reality more than the textbook ideal.

Does GHRP-2 affect hair, prostate, or erythrocyte production?

Where GHRP-2 elevates downstream testosterone or DHT signalling, hair loss in genetically susceptible men is a theoretical consideration; prostate effects and erythrocyte expansion are dose-dependent concerns particularly for men over 40. Routine monitoring (PSA, hematocrit) is appropriate for any protocol producing meaningful androgenic shifts.

What is the evidence base for GHRP-2?

GHRP-2's evidence base sits at research level investigational. The references on this page summarise 2 primary publications supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The male physiology interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

What does GHRP-2 stack well with?

For male physiology protocols, GHRP-2 pairs with compounds on complementary pathways: Kisspeptin, Gonadorelin (GnRH), PT-141. These pairings are selected because they engage independent receptor systems from GHRP-2's primary mechanism (Selective ghrelin/GHSR receptor agonist on pituitary somatotrophs), producing additive or synergistic effects rather than receptor competition.

Clinical Protocol

Start a GHRP-2 Protocol

Alukard provides physician-supervised men's health protocols with GMP-certified GHRP-2 and GMP-certified compounds with comprehensive hormone panels.

Get Protocol

Quick Facts

Molecular weight: 817 Da
Sequence length: 6 aa
Half-life: ~15-60 min
WADA: Banned (S2)
FDA: Approved in Japan for GH stimulation testing only

Stack Partners

Kisspeptin

Gonadorelin (GnRH)

PT-141

Ipamorelin

CJC-1295 without DAC (Mod GRF 1-29)

Research Note

All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for GHRP-2 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised men's health protocols

Start Your Male Physiology Protocol for GHRP-2

Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised